Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Angiogenesis inhibitor may enhance effects of therapy with oncolytic virus

Nov. 28, 2011

Japanese researchers identify new biomarker for diagnosis/monitoring of RA

Nov. 28, 2011

Mibefradil dihydrochloride given with temozolomide in murine glioma model

Nov. 28, 2011

In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor

Nov. 28, 2011

Multicomponent natural medication may target multiple Alzheimer's disease pathways

Nov. 25, 2011

Phase III study investigates phosphate-lowering effects of SBR-759

Nov. 25, 2011

Favorable preclinical results reported for Shionogi's new anti-atherosclerotic agent

Nov. 25, 2011

New anticoagulants show promise in proof-of-concept studies in vivo

Nov. 25, 2011

Preclinical and clinical results reported for Myrexis oncolytic compounds

Nov. 25, 2011

Melphalan flufenamide evaluated in phase I/IIa study

Nov. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026